期刊文献+

RP-HPLC法测定多西他赛固体脂质纳米粒中多西他赛的含量 被引量:4

Determination of docetaxel in solid lipid nanoparticles by RP-HPLC
下载PDF
导出
摘要 目的建立RP-HPLC法测定多西他赛固体脂质纳米粒中多西他赛的含量。方法色谱柱:Century SIL BDSC18(4.6mm×200mm,5μm),检测波长:228nm,流动相:乙腈-水(体积比为60:40),流速:1.0mL·min^-1,柱温:室温。结果多西他赛与其他组分分离良好,线性1.05~21.0mg·L^-1(r=0.9999),日内、日间精密度为1.12%、1.03%,平均回收率为99.3%,RSD=0.95%。结论可作为该制剂的质量控制方法。 Objective To develop a RP-HPLC method for determination of docetaxel in solid lipid nanoparticles. Methods Separation was performed using a Century SIL BDS C18(4,6 mm × 200 mm, 5 μm), the detection wavelength was set at 228 nm. The mobile phase consisted of acetonitrile-water (V: V = 60:40) at a flow-rate of 1.0 mL·min^-1 and the column temperature was kept at the room temperature. Results Docetaxel can be well separated from other components. A linearity was obtained from 1.05 to 21.0 mL·min^-1 of docetaxel with a good correlation ( r = 0.999 9). The intra-day and inter-day precision were 1.12 % and 1.03 % respectively, and the average recoveries was 99.3 % with RSD of 0.95 % ( n = 3). Conclusions The method is rapid, simple and accurate and reliable for the determination of docetaxel in solid lipid nanoparticles.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2007年第11期700-702,共3页 Journal of Shenyang Pharmaceutical University
关键词 多西他赛 反相高效液相色谱法 固体脂质纳米粒 docetaxel RP-HPLC solid lipid nanoparticles
  • 相关文献

参考文献4

二级参考文献31

  • 1SaijoN,蔡洪川.日本抗癌新药临床前及临床研究进展[J].国外医学(药学分册),1997,24(3):163-165. 被引量:6
  • 2Kim SC, Kim DW, Shim YH, et al. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy[J]. J Control Release, 2001, 72(1-3):191-202.
  • 3Campbell RB, Balasubramanian SV, Straubinger RM. Influence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomes[J]. J Pharm Sci, 2001, 90(8):1091-1105.
  • 4Dordunoo SK, Jackson JK, Arsenault LA, et al. Taxol encapsulation in poly(epsilon-caprolactone)microspheres[J].Cancer Chemother Pharmacol, 1995, 36(4):279-182.
  • 5Mu L, Feng SS. Fabrication, characterization, and in vitro release of paclitaxel (Taxol)loaded poly(lactic-co-glycolic acid)microspheres prepared by spray drying technique with lipid/cholesterol[J]. J Control Release, 2001, 76(3):239 - 254.
  • 6Mu L, Feng SS. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol)[J]. J Control Release, 2002, 80(1-3):129-144.
  • 7Kim SY, Lee YM. Taxol-loaded block copolymer nanospheres compsed of methoxy poly(ethylene glycol)and poly (epsilon-caprolactone)as novel anticancer drug carriers [J]. Biomaterials, 2001, 22(13):1697-1704.
  • 8Cavalli R, Caputo O, Casco MR. Preparation and characterization of solid lipid nanospheres containing paclitaxel [J]. Eur J Pharm Sci , 2000, 10(4):305-309.
  • 9Fromes Y, Gounon P, Veitia R, et al. Influence of microtubule-associated proteins on the differential effects of paclitaxelanddocetaxel[J]. JProtein Chem, 1996, 15(4):377-388.
  • 10Miglietta A, Bocca C, Gabriel L. Comparative studies on biological activity of certain microtubule-interacting taxanes [J]. Chem BiolInteract, 2002, 139(3):283-299.

共引文献53

同被引文献30

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部